Trial site
Xianning Central Hospital
- 9running trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Irritable bowel syndrome2 trials
- Stroke2 trials
- Acute myeloid leukaemia1 trial
- Coronary artery disease1 trial
- Multiple myeloma1 trial
- Obesity1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Recruiting4 trials
- Not yet recruiting3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Eli Lilly and Company2 trials
- Beijing Tiantan Hospital1 trial
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- Fuling Zhou1 trial
- Tongji Hospital1 trial
- and 3 more
Running trials
Recruiting
Recruiting
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Recruiting
Not yet recruiting
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
Recruiting
Not yet recruiting
Active, not recruiting
Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
Active, not recruiting
Recruiting
MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Irritable bowel syndrome2 recruiting
- Acute myeloid leukaemia1 recruiting
- Multiple myeloma1 recruiting
- Obesity1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Site data: ClinicalTrials.govUpdated 13 Nov 2026